Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: Results from CALGB 9581.
Journal of Clinical Oncology.
Times cited: 44
QUASAR results: The prognostic validity of a colon cancer recurrence score and the role of multigene profiles in determining risk.
Current Colorectal Cancer Reports.
Times cited: 3